Concurrently, Moody’s affirmed its “Aa2” rating on IU Health’s outstanding bonds.
The assignment and affirmation are a result of several factors, including the health system’s strong operating performance, healthy regional market position, sustained margins and liquidity growth. Moody’s also acknowledged IU Health’s increasingly competitive market, high reliance on government payers and upcoming period of high capital spending.
The outlook is stable, reflecting Moody’s expectation that IU Health will maintain solid margins and healthy liquidity metrics to support the period of high capital spending.
More articles on healthcare finance:
Mission Hospital to name cancer institute after donors of record-setting gift
7 latest hospital credit downgrades
10 hospitals seeking RCM talent
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
